Table 4.

Degree of rise in coated-platelets above patient’s baseline after aSAH

Clinical outcome	n	Mean ± SD	Median (IQR)	P value
DCI (n = 33)
Yes	22	18.1 ± 9.6	17.0 (11.0–20.4)	0.03*
No	11	10.6 ± 8.0	9.1 (6.0–18.4)
MOCA (n = 24)
< 26	11	17.0 ± 7.8	15.6 (11.0–20.4)	0.05
≥ 26	13	10.7 ± 7.4	9.1 (6.1–17.0)
mRS (n = 27)
3–6	8	24.8 ± 10.5	20.9 (16.4–34.7)	0.001*
0–2	19	11.9 ± 7.6	11.0 (6.1–18.4)
Surgical procedure (n = 33)
Clip ligation	25	15.4 ± 8.5	15.4 (9.1–20.0)	0.88
Coil embol.	8	16.1 ± 13.4	13.4 (4.4–25.0)

The asterisk indicates a significant difference between patient’s follow-up baseline and peak level achieved during hospitalization (at a significance level of 0.05)

aSAH aneurysmal subarachnoid hemorrhage, DCI delayed cerebral ischemia, IQR interquartile range, MOCA Montreal cognitive assessment test, mRS modified Rankin scale, SD standard deviation